December 14, 2020

Galveston firm gets $10 million to study radiation antidote

By MYER LEE The Daily News  Dec 13, 2020  Darrell Carney’s company, Chrysalis BioTheraputics, received $10.4 million to continue developing TP508, a drug that remedies the effects of radiation exposure.  JENNIFER REYNOLDS/The Daily News Chrysalis BioTherapeutics, a clinical stage biopharmaceutical company based in Galveston, is positioned to revolutionize lives worldwide.  Chrysalis recently received $10.4 million

Read More »